LITHIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lithium, and what generic alternatives are available?
Lithium is a drug marketed by Able, Alembic Ltd, Apotex Inc, Glenmark Pharms Ltd, Hetero Labs Ltd Iii, Hikma, Pharmobedient, Usl Pharma, Watson Labs, Alembic, Glenmark Pharms, Heritage Pharma, Hikma Intl Pharms, Unique, Pfizer, Sun Pharm Inds Inc, Pai Holdings Pharm, Rubicon Research, and Sciegen Pharms. and is included in thirty-three NDAs.
The generic ingredient in LITHIUM is lithium citrate. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the lithium citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lithium
A generic version of LITHIUM was approved as lithium citrate by PAI HOLDINGS PHARM on May 21st, 1986.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LITHIUM?
- What are the global sales for LITHIUM?
- What is Average Wholesale Price for LITHIUM?
Summary for LITHIUM
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 33 |
| Drug Prices: | Drug price information for LITHIUM |
| Drug Sales Revenues: | Drug sales revenues for LITHIUM |
| What excipients (inactive ingredients) are in LITHIUM? | LITHIUM excipients list |
| DailyMed Link: | LITHIUM at DailyMed |
US Patents and Regulatory Information for LITHIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | LITHIUM CITRATE | lithium citrate | SYRUP;ORAL | 018421-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma Intl Pharms | LITHIUM CARBONATE | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 076490-001 | Jun 17, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Heritage Pharma | LITHIUM CARBONATE | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 205532-001 | Sep 29, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmobedient | LITHIUM CARBONATE | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 202288-001 | Jun 29, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
